Table 5 Summary of susceptibility profiles of aerobic bacteria
From: The role of Enterococcus spp. and multidrug-resistant bacteria causing pyogenic liver abscesses
All gram-positive aerobes including Enterococcus spp. | ||||
Antibiotics | Susceptible (%) | Intermediate (%) | Resistant (%) | Total: |
Ampicillin | 21 (44.7) | 0 (0) | 26 (55.3) | 47 |
Amox/Clav. | 21 (44.7) | 0 (0) | 26 (55.3) | 47 |
Pip/Taz. | 21 (47.7) | 0 (0) | 23 (52.3) | 44 |
Cefuroxime | 12 (19.0) | 0 (0) | 51 (81.0)a | 63 |
Cefotaxime | 10 (20.4) | 0 (0) | 39 (79.6)a | 49 |
Gentamycin | 27 (51.9) | 0 (0) | 25 (48.1) | 52 |
Tigecycline | 42 (100) | 0 (0) | 0 (0) | 42 |
Levofloxacin | 21 (35.0) | 2 (3.3) | 37 (61.7) | 60 |
Vancomycin | 43 (76.8) | 0 (0) | 13 (23.2) | 56 |
Imipenem | 13 (34.2) | 0 (0) | 25 (65.8) | 38 |
Linezolid | 44 (97.8) | 1 (2.2) | 0 (0) | 45 |
Enterococcus spp. only | ||||
Antibiotics | Susceptible (%) | Intermediate (%) | Resistant (%) | Total: |
Ampicillin | 12 (31.6) | 0 (0) | 26 (68.4) | 38 |
Erythromycin | 9 (25.0) | 3 (8.3) | 24 (66.7) | 36 |
Imipenem | 13 (34.2) | 0 (0) | 25 (65.8) | 38 |
Tigecycline | 32 (100) | 0 (0) | 0 (0) | 32 |
Vancomycin | 21 (60.0) | 0 (0) | 14 (40.0) | 35 |
Teicoplanin | 35 (92.1) | 1 (2.6) | 2 (5.3) | 38 |
Levofloxacin | 10 (26.3) | 1 (2.6) | 27 (71.1) | 38 |
Linezolid | 33 (97.1) | 1 (2.9) | 0 (0) | 34 |
Daptomycin | 7 (87.5) | 0 (0) | 1 (12.5) | 8 |
All gram-negative aerobes | ||||
Antibiotics | Susceptible (%) | Intermediate (%) | Resistant (%) | Total: |
Ampicillin | 8 (15.1) | 1 (1.9) | 44 (83.0) | 53 |
Amox/Clav | 17 (33.3) | 5 (9.8) | 29 (56.9) | 51 |
Pip/Taz | 30 (52.6) | 6 (10.5) | 21 (36.8) | 57 |
Cefuroxime | 17 (33.3) | 8 (15.7) | 26 (51.0) | 51 |
Cefotaxime | 30 (60.0) | 0 (0) | 20 (40.0) | 50 |
Ceftazidim | 10 (66.7) (52.2) | 2 (13.3) | 3 (20.0) | 15 |
Imipenem | 53 (84.1) | 3 (4.8) | 7 11.1) | 63 |
Meropenem | 55 (90.2) | 1 (1.6) | 5 (8.2) | 61 |
Gentamicin | 52 (83.9) | 0 (0) | 10 (16.1) | 62 |
Tigecycline | 35 (71.4) | 4 (8.2) | 10 (20.4) | 49 |
TMP/SMX | 42 (73.7) | 0 (0) | 15 (26.3) | 57 |
Levofloxacin | 42 (68.9) | 2 (3.3) | 17 (27.9) | 61 |
Ciprofloxacin | 41 (68.3) | 1 (1.7) | 18 (30.0) | 60 |